Download presentation
Presentation is loading. Please wait.
Published byGyles Robinson Modified over 9 years ago
1
DRUG INTERACTIONS I Lecture #36
2
Drug Interactions Terms Therapeutic Drug Interaction ADR Additive Synergism
3
DDIs PD – complementary responses – opposing responses PK – induce metabolism – inhibit metabolism – reduce absorption – decrease volume distribution – alter renal clearance
4
PD nAChR = nicotinic acetylcholine receptor GABA A = - aminobutyric acid receptor Mutual Sedative Effects No Counter Ion competitive antagonist GABA A agonist
5
PD μ-opioid receptor competitive antagonist μ-opioid receptor agonist NMDA = N-methyl-D-aspartate receptor for opioid overdose opioid analgesic
6
PK: Induce Metabolism CYP2C9 anticoagulant antibiotic warfarin
8
PK: Inhibit Metabolism Sedative HIV protease inhibitor
9
PK: Inhibit Metabolism antibiotic Metabolites CYP3A4 inhibits
10
PK: Reduced Absorption antacid log P = 4.63 + reduce gastric pH hydrophobic drug = Decreased Absorption
11
PK: Decrease Volume Distribution log P = 3.44 log P = 1.26 Quinidine displaces digoxin from tissues Reduces volume distribution (V)
12
PK: Renal Clearance Na + Lithium
13
Drug Combinations: Inhibit Metabolism HIV protease inhibitor CYP3A4 inhibitor Decrease Clearance Increase Oral Bioavailability = 12 hr = 8 hr
14
Drug Combinations: Inhibit Metabolism Parkinson’s Disease
15
Drug Combinations: Inhibit Metabolism Metabolites renal dehydropeptidase penicillin antibiotic dehydropeptidase inhibitor
16
PK: Inhibit Bacterial Enzymes -lactam antibiotic bacterial -lactamase Inactive antibiotic mechanism-based β-lactamase inhibitor
17
Interaction Types Mutual Effects – Competing for the same target Bidirectional Effects – Unidirectional Effects – A B Beneficial Interactions
18
Mutual Effects
20
D = Displaced C = Control Total Unbound
22
Mutual Effects anti-seizure Extraction Ratio?
23
Bidirectional anti-seizure diuretic Absorption diuretic anti-seizure Renal Clearance
24
Unidirectional Antibiotic Metabolites Chronic Obstructive Pulmonary Disease CYP1A2 Antibiotic Metabolites No Effect
25
Unidirectional
26
enoxacin
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.